Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E

T P Herbert1, R Fåhraeus, A Prescott

  • 1Department of Anatomy and Physiology, MSI/WTB Complex, University of Dundee, UK. t.p.herbert@dundee.ac.uk

Current Biology : CB
|July 19, 2000
PubMed

Insights

Overexpression of eukaryotic initiation factor 4E (eIF4E) drives cancer. Novel peptides targeting eIF4E induce apoptosis, revealing a direct role for eIF4E in cell survival independent of translation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Overexpression of eukaryotic initiation factor 4E (eIF4E) promotes cell transformation and is implicated in human cancers.
  • eIF4E availability regulates mRNA translation and cell growth by forming initiation complexes with eIF4G.
  • eIF4E-binding proteins (4E-BPs) inhibit eIF4E availability, and their overexpression can reverse eIF4E-induced cell transformation.

Purpose of the Study:

  • To investigate the role of eIF4E in cell transformation using novel peptide inhibitors.
  • To explore the mechanism by which eIF4E influences cell survival and apoptosis.

Main Methods:

  • Development of peptides mimicking eIF4E-binding motifs from 4E-BPs and eIF4G, linked to a cell-penetrating sequence.
  • Introduction of these peptides into MRC5 cells to observe effects on cell viability and apoptosis.
  • Site-directed mutagenesis (alanine substitutions) to assess the importance of eIF4E binding for peptide activity.

Main Results:

  • Peptides designed to bind eIF4E induced rapid, dose-dependent apoptosis in MRC5 cells.
  • Alanine substitutions impairing eIF4E binding significantly reduced the apoptotic effect.
  • A peptide with abolished eIF4E binding failed to induce apoptosis, confirming eIF4E binding as the mechanism.
  • Apoptosis induction was independent of protein synthesis inhibition.

Conclusions:

  • The study demonstrates that eIF4E plays a direct role in promoting cell survival.
  • This pro-survival role of eIF4E is distinct from its established function in mRNA translation.
  • Targeting eIF4E with specific peptides represents a potential therapeutic strategy for cancers associated with eIF4E overexpression.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...